CLINICAL_TRIALS
trial_result
· 2018-07-09
Clinical Trial Update: Treatment With Omalizumab to Improve the Asthmatic Response to Rhinovirus Experimental Infection With Rhinovirus [Phase 2]
Summary
Phase 2 trial evaluating whether omalizumab improves the asthmatic response to rhinovirus infection; the study has completed and results were posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Virginia | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2018-07-09